Trials that use: P-values
New to this method? Read the tutorial →
10,701 results
- FirstStep2Health Intervention: Complete Statistical AnalysisIndependent statistical analysis of FirstStep2Health Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04164277).
- FISATABIIndependent statistical analysis of Feasibility of Improving Sleep Apnea Treatment Adherence After Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04221009).
- Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study: Complete Statistical AnalysisIndependent statistical analysis of Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01285362).
- Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- FITESTIndependent statistical analysis of Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- FITSTART+Independent statistical analysis of Parent Feedback Intervention Targeting Student Transitions and Alcohol Related Trajectories (+) Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896): Complete Statistical AnalysisIndependent statistical analysis of Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691): Complete Statistical AnalysisIndependent statistical analysis of Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691): primary endpoint results, effect estimate with confidence…
- FLAMEIndependent statistical analysis of the FLAME phase 3 trial of QVA149 versus LABA/ICS in COPD, including exacerbation rates, time-to-event analyses, non-inferiority methodology, safety, and statistical interpretation.
- FLAMEComplete statistical analysis of the FLAME phase 3 trial of fluorometholone 0.1% ophthalmic suspension as adjunctive therapy after trichiasis surgery, including trial design, registered endpoints, statistical methods, reported results, safety, and interpretation.
- FLAMEIndependent statistical analysis of Flexibility, Alcohol Misuse, and Excitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06634771).
- FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides): Complete Statistical AnalysisIndependent statistical analysis of FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides): primary endpoint results, effect estimate with confidence…
- Flatbush FHC Proactive Colorectal Cancer Screening and Navigation: Complete Statistical AnalysisIndependent statistical analysis of Flatbush FHC Proactive Colorectal Cancer Screening and Navigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05646355).
- FLAURA2Independent statistical analysis of FLAURA2, the randomized phase 3 trial of osimertinib with chemotherapy versus osimertinib alone in first-line treatment of EGFR-mutated non-small cell lung cancer. Includes trial design, endpoints, survival analyses,…
- FLAXPADIndependent statistical analysis of Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- FLEXIndependent statistical analysis of Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Flex HDIndependent statistical analysis of Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or…
- FLEX MIndependent statistical analysis of A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FLEX VIndependent statistical analysis of A Study in Participants With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01202773).
- Flex-UpIndependent statistical analysis of A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence…
- Florbetapir Calibration to the Centiloid Scale: Complete Statistical AnalysisIndependent statistical analysis of Florbetapir Calibration to the Centiloid Scale: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02120664).
- FLOREYIndependent statistical analysis of Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FLOWIndependent statistical analysis of the FLOW phase 3 trial of semaglutide versus placebo in people with type 2 diabetes and chronic kidney disease, including trial design, the composite renal endpoint, Cox proportional-hazards…
- FLOWIndependent statistical analysis of A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease: primary endpoint results, effect estimate with confidence…
- FLUBUTBIIndependent statistical analysis of Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01366612).
- Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight: Complete Statistical AnalysisIndependent statistical analysis of Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL): Complete Statistical AnalysisIndependent statistical analysis of Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma: Complete Statistical AnalysisIndependent statistical analysis of Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma: primary endpoint results, effect estimate with confidence interval, sample-size…
- Fluid Balance in the ICU – Interventions to Minimize Fluids in Patients With Septic Shock: Complete Statistical AnalysisIndependent statistical analysis of Fluid Balance in the ICU - Interventions to Minimize Fluids in Patients With Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Fluid Chloride and AKI in Cardiopulmonary Bypass: Complete Statistical AnalysisIndependent statistical analysis of Fluid Chloride and AKI in Cardiopulmonary Bypass: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02668952).
- Flumazenil for the Treatment of Primary Hypersomnia: Complete Statistical AnalysisIndependent statistical analysis of Flumazenil for the Treatment of Primary Hypersomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01183312).
- Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy: Complete Statistical AnalysisIndependent statistical analysis of Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00695318).
- FLUORESCEIndependent statistical analysis of Fluoxetine for Visual Recovery After Ischemic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02737930).
- Fluorescent Evaluation of Colorectal Anastamoses: Complete Statistical AnalysisIndependent statistical analysis of Fluorescent Evaluation of Colorectal Anastamoses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01424293).
- Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases: Complete Statistical AnalysisIndependent statistical analysis of Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases: primary endpoint results, effect estimate with confidence…
- Fluoroscopy-guided Versus Traditional Placement of Epidural Catheters: Complete Statistical AnalysisIndependent statistical analysis of Fluoroscopy-guided Versus Traditional Placement of Epidural Catheters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02678039).
- Fluticasone Nasal Spray Patient Preference Study: Complete Statistical AnalysisIndependent statistical analysis of Fluticasone Nasal Spray Patient Preference Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00398476).
- FMBI With War-affected Families: Complete Statistical AnalysisIndependent statistical analysis of FMBI With War-affected Families: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05241314).
- FMT for FIIndependent statistical analysis of Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FMT ObesityIndependent statistical analysis of Fecal Microbiota Transplantation for the Treatment of Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02741518).
- Focal Prostate Radio-Frequency Ablation: Complete Statistical AnalysisIndependent statistical analysis of Focal Prostate Radio-Frequency Ablation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02328807).
- Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT): Complete Statistical AnalysisIndependent statistical analysis of Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00135811).
- FOCUSIndependent statistical analysis of A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- FOCUSIndependent statistical analysis of An Efficacy and Safety Study of Fremanezumab in Adults With Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FOCUSIndependent statistical analysis of Functional Recovery and Caregiver Burden Following Surgery in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01382251).
- FOGIndependent statistical analysis of Amyloidopathy, Cholinopathy, Dopamine Responsiveness and Freezing of Gait in PD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03647137).
- FOHSIndependent statistical analysis of Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor: Complete Statistical AnalysisIndependent statistical analysis of Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor: primary endpoint results, effect estimate with confidence interval,…
- FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01688336).